Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial
Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check20 days agoChange DetectedA notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record. It does not change the trial details or version history.SummaryDifference0.5%

- Check27 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check34 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedNew entries were added for 'Find contact information' and 'Study Status' on the page, accompanying an updated revision label to v3.7.0 dated 2026-09-14. The old label 'Find Contact Information' was removed and the revision label v3.6.6 was deleted, indicating a rewording and content update.SummaryDifference0.4%

- Check76 days agoChange DetectedA new revision entry labeled v3.6.6 was added to the page history, while the prior revision v3.6.5 was removed, reflecting an update to the page's versioning in the history list.SummaryDifference0.1%

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.